Neopeptine

# Neopeptine ## Overview - **Classification**: Digestive Enzyme Preparation - **Mechanism**: Contains Fungal Diastase (amylolytic enzyme) and Papain (proteolytic enzyme). These enzymes aid in the breakdown of complex carbohydrates and proteins, facilitating digestion. ## Primary Indications 1. **Dyspepsia/Indigestion** - Relief of symptoms like bloating, gas, fullness. 2. **Flatulence** - Reduction of gas accumulation in the gastrointestinal tract. 3. **Maldigestion** - Support for conditions where natural enzyme production is insufficient. ## Adult Dosing ### Standard Dosing **Dyspepsia/Indigestion/Flatulence** - **Dose**: **5 mL** to **10 mL** (1 to 2 teaspoonfuls) - **Frequency**: 2 to 3 times daily - **Route**: Oral - **Duration**: As needed for symptom relief ### Dose Adjustments - **Renal Impairment**: No specific dose adjustment generally needed; acts locally in GI tract. - **Hepatic Impairment**: No specific dose adjustment generally needed. - **Elderly Patients**: Use standard adult dose; no specific adjustment required. ## Pediatric Dosing ### Neonates (0-28 days) - **Dose**: **0.5 mL** (**10 drops**) - **Frequency**: Once daily or as directed by physician - **Maximum**: **0.5 mL** per day (unless otherwise advised) - **Special Notes**: Use with caution; consult a pediatrician before administration due to limited data. ### Infants (1-12 months) - **Dose**: **0.5 mL** to **1 mL** (**10 to 20 drops**) - **Frequency**: 2 to 3 times daily - **Maximum**: **3 mL** per day (maximum of 1 mL per dose, 3 times daily) ### Children (1-12 years) - **Dose**: **2.5 mL** to **5 mL** (½ to 1 teaspoonful) - **Frequency**: 2 to 3 times daily - **Maximum**: **15 mL** per day (maximum of 5 mL per dose, 3 times daily) ### Adolescents (13-18 years) - **Dose**: Administer as **adult dosing** of **5 mL** to **10 mL**. - **Maximum**: **30 mL** per day (maximum of 10 mL per dose, 3 times daily). ## Safety Information ### Contraindications - **Absolute**: Hypersensitivity to Fungal Diastase, Papain, or any component. - **Relative**: Acute pancreatitis or exacerbation of chronic pancreatitis (use with caution). ### Common Adverse Effects - **Common (1-10%)**: Mild abdominal discomfort, nausea. - **Common (1-10%)**: Diarrhea or constipation. - **Serious but Rare**: Allergic reactions (rash, itching, swelling, severe dizziness, trouble breathing). ### Key Drug Interactions - **Antacids/PPIs**: May reduce enzyme activity if taken simultaneously; separate administration. - **Oral Hypoglycemics**: Theoretical interaction due to improved carbohydrate digestion, but rarely clinically significant. ## Monitoring & Follow-up - **Before Treatment**: No specific tests usually required. - **During Treatment**: Monitor for improvement in GI symptoms. - **Clinical Signs**: Watch for persistent or worsening symptoms, or any signs of allergic reaction. ## Clinical Pearls - 💡 **Timing**: Administer **after meals** to optimize enzyme activity on food. - 💡 **Administration**: Shake the bottle well before use. - 💡 **Storage**: Store in a cool, dry place, away from direct sunlight. - 💡 **Expectations**: Not a cure for underlying conditions; provides symptomatic relief. > **⚠️ Important**: This information is for educational purposes only. Always consult current prescribing information, local guidelines, and clinical judgment before prescribing.